Sector ratings Hangzhou Tigermed Consulting Co., Ltd

Equities

End-of-day quote Shenzhen S.E. Other stock markets 2026-03-06			5-day change	1st Jan Change
57.37 ^CNY	+1.06%		-3.81%	+1.18%

Mar. 03	Frontage Unit Acquires Research Lab Firm from Tigermed Consulting Unit	MT
Feb. 13	Beijing Trimmune Biotech Co., Ltd. announced that it has received funding from Hangzhou Tigermed Consulting Co., Ltd	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
HANGZHOU TIGERMED CONSULTING CO., LTD	6.78B		AAA
LONZA GROUP AG	45.49B		AAA
BEONE MEDICINES AG	33.41B		-
CELLTRION, INC.	31.32B		A
IQVIA HOLDINGS INC.	29.29B		AAA
REVOLUTION MEDICINES, INC.	19.5B	-	B	-		-
ASCENDIS PHARMA A/S	14.77B		-	-
MEDPACE HOLDINGS, INC.	13.36B		BBB
EUROFINS SCIENTIFIC SE	13.21B		AA
IONIS PHARMACEUTICALS, INC.	12.23B	-	A	-		-
REGENCELL BIOSCIENCE HOLDINGS LIMITED	11.55B	-	-	-	-	-	-	-
TEMPUS AI, INC.	9.34B		A			-
QIAGEN N.V.	9.18B		AAA
PRAXIS PRECISION MEDICINES, INC.	8.65B	-	B	-		-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	8.59B	-	A	-		-
ABIVAX	8.49B	-	BBB	-		-
BIO-TECHNE CORPORATION	8.43B		A
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-		-	-	-
ICON PUBLIC LIMITED COMPANY	8.19B		AA
KYMERA THERAPEUTICS, INC.	6.82B	-	BBB	-		-
Average	15.35B		A
Weighted average by Cap.			A